NATCOPHARMNATCOPHARM
daily timeframe
i just shared my experience it is not an invite or recommendation to trade.
if youn any doubt means Please leave comments for any query.
best wishes
DYSON
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
91.40 INR
13.88 B INR
39.81 B INR
87.45 M
About NATCO PHARMA LTD.
Sector
CEO
Rajeev Nannapaneni
Headquarters
Hyderabad
Website
Founded
1981
ISIN
INE987B01026
FIGI
BBG000F4LTG0
NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.
NATCOPHARMA :NSE BULLISH FLAG & TRENDLINE BO DTF/WTFNATCOPHARMA STOCK Analysis
TRADE PLAN (DTF Close Price for SWING /POSITIONAL)
ENTRY - 1413 50% Qty, Add 50% qty 1482 DTF Close
SL - 1320
TARGET --01- 1482 SWING , TGT02--1624
Hold For a 6M -1 Year or TGT 2
Chart Pattern :
STOCK had a 3Month Streak to Touch an ATH of 1639, Retracing
NatcopharmNatcopharm
CMP
Downtrend channel break
If sustains above
50 EMA then good up move possible
Natco Pharma- A multibagger?NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.
The Company has also forayed into Crop health and completed state-of-the-art greenfield m
NATCOPHARM - Bullish oNStock name - Natco Pharma Limited.
✅#NATCOPHARM
✅Next resistance 670
✅Moved 52% in 27 weeks.
Weekly chart
Chart is self explanatory everything.
Master score - B
Disclaimer : This is for demonstration and education purpose only. This is not buying and selling recommendation. I'm not SEBI registered.
Natco Pharma Breakout Retest! 🚀
Hey Dosto! 👋
🔍 Chart Analysis: Natco Pharma - CMP 980 📊
🚀 Reasons for Trade:
Strong Uptrend
Cup and Handle Breakout Retest
💹 Trade Details:
CMP: 980
SL: 918
Targets: 1090, 1188
🌟 Why Natco Pharma? After a cup and handle breakout, Natco Pharma has retraced for a retest, indicating potential upwa
NATCO PHARMA longterm breakout monthly horizonatal and trendlinecmp 1259
sl 1145
target 1470
monthly breakout
rounding bottom
horizontal line breakout
trendline breakout
NATCOPHARMA Weekly ChartCup & Handle Breakout
Retest level 935
Taken support 9 EMA and bounced
support 845
RSI above 60 Weekly / Monthly
Daily RSI 58
EMA are in line
Expected level 1189 and above
NATCO PHARMA LTD S/R Support and Resistance Levels:
Support Levels: These are price points (green line/share) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline.
Resistance Levels: Conversely, resistance levels (re
Momentum Trading Picks - Pharma Stock Natco Pharma.This chart is very interesting as well as confusing at the same time for some people let's break it down step by step.
If you see the monthly chart of Natco Pharma you will notice many patterns there like:-
Cup pattern
W pattern
Pole and flag Pattern
Volume is increasing significantly
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NATCOPHARM is 1,407.15 INR — it has decreased by −1.70% in the past 24 hours. Watch NATCO PHARMA LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange NATCO PHARMA LTD. stocks are traded under the ticker NATCOPHARM.
NATCOPHARM stock has fallen by −2.07% compared to the previous week, the month change is a −1.85% fall, over the last year NATCO PHARMA LTD. has showed a 87.12% increase.
We've gathered analysts' opinions on NATCO PHARMA LTD. future price: according to them, NATCOPHARM price has a max estimate of 1,675.00 INR and a min estimate of 690.00 INR. Watch NATCOPHARM chart and read a more detailed NATCO PHARMA LTD. stock forecast: see what analysts think of NATCO PHARMA LTD. and suggest that you do with its stocks.
NATCOPHARM reached its all-time high on Sep 12, 2024 with the price of 1,639.00 INR, and its all-time low was 1.70 INR and was reached on Jul 10, 2001. View more price dynamics on NATCOPHARM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NATCOPHARM stock is 2.78% volatile and has beta coefficient of 0.74. Track NATCO PHARMA LTD. stock price on the chart and check out the list of the most volatile stocks — is NATCO PHARMA LTD. there?
Today NATCO PHARMA LTD. has the market capitalization of 252.02 B, it has increased by 3.22% over the last week.
Yes, you can track NATCO PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
NATCO PHARMA LTD. is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
NATCOPHARM earnings for the last quarter are 37.30 INR per share, whereas the estimation was 24.70 INR resulting in a 51.01% surprise. The estimated earnings for the next quarter are 32.95 INR per share. See more details about NATCO PHARMA LTD. earnings.
NATCO PHARMA LTD. revenue for the last quarter amounts to 13.63 B INR, despite the estimated figure of 12.67 B INR. In the next quarter, revenue is expected to reach 13.17 B INR.
NATCOPHARM net income for the last quarter is 6.68 B INR, while the quarter before that showed 3.86 B INR of net income which accounts for 73.05% change. Track more NATCO PHARMA LTD. financial stats to get the full picture.
NATCO PHARMA LTD. dividend yield was 1.00% in 2023, and payout ratio reached 12.28%. The year before the numbers were 0.98% and 14.04% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has 4.80 K employees. See our rating of the largest employees — is NATCO PHARMA LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NATCO PHARMA LTD. EBITDA is 20.28 B INR, and current EBITDA margin is 45.72%. See more stats in NATCO PHARMA LTD. financial statements.
Like other stocks, NATCOPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NATCO PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NATCO PHARMA LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NATCO PHARMA LTD. stock shows the buy signal. See more of NATCO PHARMA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.